Detailed information for compound 49131

Basic information

Technical information
  • TDR Targets ID: 49131
  • Name: 6-[(3,5-dimethylphenyl)methyl]-2-(methylsulfa nylmethylsulfanyl)-5-propan-2-yl-1H-pyrimidin -4-one
  • MW: 348.526 | Formula: C18H24N2OS2
  • H donors: 1 H acceptors: 3 LogP: 5.58 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSCSc1nc(Cc2cc(C)cc(c2)C)c(c(n1)O)C(C)C
  • InChi: 1S/C18H24N2OS2/c1-11(2)16-15(9-14-7-12(3)6-13(4)8-14)19-18(20-17(16)21)23-10-22-5/h6-8,11H,9-10H2,1-5H3,(H,19,20,21)
  • InChiKey: LLRHMUNEFHEADF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 6-[(3,5-dimethylphenyl)methyl]-5-isopropyl-2-(methylsulfanylmethylsulfanyl)-1H-pyrimidin-4-one
  • 6-[(3,5-dimethylphenyl)methyl]-5-isopropyl-2-[(methylthio)methylthio]-1H-pyrimidin-4-one
  • 6-(3,5-dimethylbenzyl)-5-isopropyl-2-[(methylthio)methylthio]-1H-pyrimidin-4-one
  • 5-Isopropyl-2-[(methylthiomethyl)thio]-6-(3,5-dimethylbenzyl)-pyrimidin-4-(1H)-one
  • AIDS-059599
  • AIDS059599

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 reverse transcriptase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trypanosoma brucei RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
Schistosoma mansoni hypothetical protein Get druggable targets OG5_139608 All targets in OG5_139608
Trypanosoma congolense RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
Plasmodium yoelii integrase-related Get druggable targets OG5_139608 All targets in OG5_139608

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.0288 0.9823 0.5
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.0288 0.9823 0.5
Trypanosoma brucei RNA helicase, putative 0.01 0.2698 1
Brugia malayi Protein kinase domain containing protein 0.0288 0.9823 0.5
Loa Loa (eye worm) hypothetical protein 0.0288 0.9823 0.5
Loa Loa (eye worm) TKL/MLK/LZK protein kinase 0.0288 0.9823 0.5
Loa Loa (eye worm) hypothetical protein 0.0288 0.9823 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.01 uM Compound was evaluated for inhibition of p24 production in HIV infected peripheral blood mononuclear cells ChEMBL. 9873370
IC50 (binding) = 4.8 uM Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase ChEMBL. 9873370
IC50 (binding) = 4.8 uM Compound was evaluated for enzymatic inhibitory activity against recombinant HIV reverse transcriptase ChEMBL. 9873370
IC50 (functional) > 100 uM Compound was evaluated for cytotoxic activity against peripheral blood mononuclear cells using microculture tetrazolium assay ChEMBL. 9873370

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.